| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 10/20/2004 | CN1537531A Celecoxib compositions |
| 10/20/2004 | CN1537529A Disinfectant liquid for skin membrana mucosa and sound |
| 10/20/2004 | CN1537527A Prescription of mineral water bathing for treating skin diseases |
| 10/20/2004 | CN1171997C Modified TLE-2-receptor ligands |
| 10/20/2004 | CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| 10/20/2004 | CN1171883C Nonsteroidal antiinflammatories |
| 10/20/2004 | CN1171874C Combinations of protein farnesyltransferase and HMG COA reductase inhibitors and their use to treat cancer |
| 10/20/2004 | CN1171635C Topical composition containing human epidermal growth factor |
| 10/20/2004 | CN1171629C Chapstick and preparing method thereof |
| 10/20/2004 | CN1171628C Ointment for eliminating macula and its preparation method |
| 10/20/2004 | CN1171622C Medicine for treating dermatosis and its prepn. method |
| 10/20/2004 | CN1171613C Medcine for external applicationf or curing dermal viral infection and its preparation method |
| 10/20/2004 | CN1171609C Medicine for anti-microwave, radiation and reducing toxic and side effect of radiotherapy and chemotherapy and its preparation method |
| 10/20/2004 | CN1171604C Liquid method for growing hair |
| 10/20/2004 | CN1171601C Medicine for treating nephrosis and lung disease |
| 10/20/2004 | CN1171600C Burnt ointment and its preparing process |
| 10/20/2004 | CN1171597C Composite medicine for treating burns and its prepn. method |
| 10/20/2004 | CN1171592C Application of seaweed oligose |
| 10/20/2004 | CN1171588C Application of ivermectin for preparing medicine for treatment of seborrhea |
| 10/20/2004 | CN1171579C Foaming compsn. for hair care |
| 10/20/2004 | CN1171562C Microdermabrasion device |
| 10/19/2004 | US6806370 NK-1 receptor active amine oxide prodrugs |
| 10/19/2004 | US6806274 Quinazoline derivatives |
| 10/19/2004 | US6806273 Compounds |
| 10/19/2004 | US6806262 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 10/19/2004 | US6806261 Control release transforming growth factor; central nervous system disorders; antiproliferative agent |
| 10/19/2004 | US6806255 Compounds and methods for modulating adhesion molecule function |
| 10/19/2004 | US6806070 Use of bacterial extracts of the pseudomonadaceae family as cosmetic agents |
| 10/19/2004 | US6806059 Nucleotide sequences coding enzymatic polypeptide for use innthe treatment of asthma, and for use in laundry detergent and stain removers |
| 10/14/2004 | WO2004087763A1 Modified antibody against cd22 and utilization thereof |
| 10/14/2004 | WO2004087202A2 Pharmaceutical composition comprising a macrolide immunomodulator |
| 10/14/2004 | WO2004087195A2 Therapeutic use of modulators of notch and/or kruppel-like factors |
| 10/14/2004 | WO2004087192A1 Pharmaceutical and cosmetic compositions which are used to prevent and treat cell ageing through the sequestration of reactive carbonyl species |
| 10/14/2004 | WO2004087188A1 Histamine binding compounds for treatment method for disease conditions mediated by neutrophils |
| 10/14/2004 | WO2004087170A1 Combination of a macrolide t-cell immunomodulator and a calciferol for the treatment of skin diseases or of inflammatory bowel disease |
| 10/14/2004 | WO2004087167A2 Pharmaceutical compositions comprising epinastine for the treatment of skin diseases |
| 10/14/2004 | WO2004087144A1 Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases |
| 10/14/2004 | WO2004087138A1 Method for treating vascular hyperpermeable disease |
| 10/14/2004 | WO2004087118A2 Synergistic combinations of macrolide t-cell modulator or inmunosuppressant and a retinoid |
| 10/14/2004 | WO2004087093A1 A topical agent containing niacin for application to the skin prior to luminous treatment |
| 10/14/2004 | WO2004067550A3 Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same |
| 10/14/2004 | WO2004016769A3 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 10/14/2004 | WO2004000781A3 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 10/14/2004 | WO2003065985A3 Uses of mammalian cytokine; related reagents |
| 10/14/2004 | WO2003031475A8 Antibodies against kdr, their production and uses |
| 10/14/2004 | WO2002045733A3 Oral preprations having itching-relievign or antipruritic activity |
| 10/14/2004 | US20040205832 Transgenically produced decorin |
| 10/14/2004 | US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions |
| 10/14/2004 | US20040204596 preventing or treating degradation of collagen, degradation of collagen by bacterial collagenases during a bacterial infection, regeneration of skin and ligaments, tumoral invasion and degenerative diseases having fibrinoid degeneration of collagen |
| 10/14/2004 | US20040204492 Topical composition and method for treating seborrheic dermatitis |
| 10/14/2004 | US20040204487 Novel medicinal product |
| 10/14/2004 | US20040204477 For use as antiproliferative agents |
| 10/14/2004 | US20040204465 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 10/14/2004 | US20040204464 Isoxazoline compounds having MIF antagonist activity |
| 10/14/2004 | US20040204437 Substituted arylamine derivatives and methods of use |
| 10/14/2004 | US20040204436 Imidazonaphthyridines |
| 10/14/2004 | US20040204433 High concentration of minoxidil; free from problems such as crystal precipitation and the like at low temperatures |
| 10/14/2004 | US20040204425 Sodium channel blockers |
| 10/14/2004 | US20040204424 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 10/14/2004 | US20040204418 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease |
| 10/14/2004 | US20040204417 For therapy of cancer |
| 10/14/2004 | US20040204408 Piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 10/14/2004 | US20040204392 use of trilostane or a 3-enol C1-4 alkanoate ester thereof; treatment of Cushing's syndrome in humans and veterinary animals |
| 10/14/2004 | US20040204391 Applying onto healed wound a composition comprising a fluid, film-forming carrier, and subsequently hardening the carrier into a tangible membrane juxtaposed to the healed wound thereby reducing scarring or improving the appearance thereof |
| 10/14/2004 | US20040204390 Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist |
| 10/14/2004 | US20040204345 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 10/14/2004 | US20040203118 Polynucleotides and polypeptides of the IFNalpha-14 gene |
| 10/14/2004 | US20040202729 for delivering sulfur containing compounds to skin and absorbing irritants in the skin; high sorption base is employed which comprises non-swelling clay, gum, swelling clay, silicon and combinations thereof; treatment of skin disorders |
| 10/14/2004 | US20040202725 Compositions for the treatment of pilosebaceous gland inflammations comprising aluminium fluoride |
| 10/14/2004 | US20040202709 Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery therof |
| 10/14/2004 | US20040202702 Method and composition for the treatment of scars |
| 10/14/2004 | US20040202672 Dermatomycosis vaccine |
| 10/14/2004 | US20040202638 plant extracts or whey extracts, excluding soybean seed extract, prevent or ameliorate aging of the skin and inhibit wrinkle formation |
| 10/14/2004 | US20040202624 Galenical formulation |
| 10/14/2004 | DE10313341A1 Verwendung von proNGF, insbesondere zur Wundheilung der Cornea und der Haut Use of proNGF, especially for wound healing of the cornea and skin |
| 10/14/2004 | CA2766702A1 A process for the preparation of ferutinine from ferula genus plants and uses therefor |
| 10/14/2004 | CA2521261A1 Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases |
| 10/14/2004 | CA2520957A1 Method for treating vascular hyperpermeable disease |
| 10/14/2004 | CA2520580A1 Histamine binding compounds for treatment method for disease conditions mediated by neutrophils |
| 10/14/2004 | CA2519958A1 Pharmaceutical composition comprising a macrolide immunomodulator |
| 10/14/2004 | CA2519096A1 Combination of a macrolide t-cell immunomodulator and a calciferol for the treatment of skin diseases or of inflammatory bowel disease |
| 10/14/2004 | CA2518245A1 Synergistic combinations of macrolide t-cell modulator or inmunosuppressant and a retinoid |
| 10/13/2004 | EP1466913A1 Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 10/13/2004 | EP1466624A1 Drug for regenerating tissue and vessel and method therefor |
| 10/13/2004 | EP1466602A1 Organ fibrosis inhibitors |
| 10/13/2004 | EP1466591A1 Cosmetic or dermatological composition obtained by lyophilisation of biotechnological polysaccharides and marine active compounds |
| 10/13/2004 | EP1466590A1 Cosmetic use of new desquamative agents |
| 10/13/2004 | EP1466585A2 Use of of aminosubstituted hydroxybenzophenones as photostable UV-filter in cosmetic and pharmaceutical preparations |
| 10/13/2004 | EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy |
| 10/13/2004 | EP1465891A2 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1465889A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 10/13/2004 | EP1465880A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
| 10/13/2004 | EP1465871A1 Pyrazole derivatives for use in diseases associated with the 5-ht2c receptor |
| 10/13/2004 | EP1465869A1 Modulators of lxr |
| 10/13/2004 | EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 10/13/2004 | EP1465854A2 Chalcone derivatives and their use to treat diseases |
| 10/13/2004 | EP1465676A1 Film-forming compositions and methods |
| 10/13/2004 | EP1465662A1 Combination treatments for allergic disease comprising administering an anti-ige antibody and antiallergic compound |
| 10/13/2004 | EP1465649A2 Methods and compositions for derepression of iap-inhibited caspase |
| 10/13/2004 | EP1465647A1 Topical cosmetic composition having a natural plant active ingredient and method of using same |